Literature DB >> 20925437

Preventability of drug-related harms - part II: proposed criteria, based on frameworks that classify adverse drug reactions.

Jeffrey K Aronson1, Robin E Ferner.   

Abstract

BACKGROUND: 'Preventability' is a crucial concept in the literature on adverse drug effects. However, a systematic review of the definitions of preventability of adverse drug effects has suggested that none fits all circumstances. Furthermore, when the reliability of these definitions has been examined they have been found to be imperfect.
OBJECTIVE: To propose and outline a method for determining the theoretical preventability of an adverse drug effect, based on frameworks for classifying adverse drug reactions - the EIDOS and DoTS methods.
METHODS: EIDOS is based on the mechanism of action of the drug. It observes that a drug (an Extrinsic species) causes an adverse effect by interacting with an Intrinsic species that is its target when the two are Distributed together, and that the resulting pathophysiological Outcome (the adverse effect) causes the Sequela (the adverse reaction). DoTS observes that the Dose-relatedness of the adverse effect compared with the beneficial effect is relevant (determining toxic, collateral, or hypersusceptibility effects), that adverse effects have Time-courses (varying from immediate to delayed), and that there are individual Susceptibility factors. RESULTS AND DISCUSSION: We have elicited many published examples that show that each of these factors in the causation of an adverse drug effect can be adduced to assess its preventability. We have constructed a flowchart that illustrates how the processes can be logically analysed.
CONCLUSIONS: This approach suggests methods for devising prospective preventive strategies and for deciding retrospectively whether an adverse reaction in an individual should have been prevented.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20925437     DOI: 10.2165/11538280-000000000-00000

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  25 in total

Review 1.  Joining the DoTS: new approach to classifying adverse drug reactions.

Authors:  J K Aronson; R E Ferner
Journal:  BMJ       Date:  2003-11-22

Review 2.  Clarification of terminology in drug safety.

Authors:  Jeffrey K Aronson; Robin E Ferner
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

3.  [Validation of a measurement scale: example of a French Adverse Drug Reactions Preventability Scale].

Authors:  Pascale Olivier; Jacques Caron; Françoise Haramburu; Jean-Louis Imbs; Annie-Pierre Jonville-Béra; Georges Lagier; Catherine Sgro; Thierry Vial; Jean-Louis Montastruc; Maryse Lapeyr-Mestre
Journal:  Therapie       Date:  2005 Jan-Feb       Impact factor: 2.070

4.  EIDOS: a mechanistic classification of adverse drug effects.

Authors:  Robin E Ferner; Jeffrey K Aronson
Journal:  Drug Saf       Date:  2010-01-01       Impact factor: 5.606

Review 5.  Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine.

Authors:  Sarah E McDowell; Jamie J Coleman; R E Ferner
Journal:  BMJ       Date:  2006-05-05

Review 6.  Malignant hyperthermia.

Authors:  R Ben Abraham; P Adnet; V Glauber; A Perel
Journal:  Postgrad Med J       Date:  1998-01       Impact factor: 2.401

Review 7.  Some pharmacokinetic aspects of the lipophilic terfenadine and zwitterionic fexofenadine in humans.

Authors:  Chen Chen
Journal:  Drugs R D       Date:  2007

8.  Daily fluctuation of plasma levels with conventional and controlled-release carbamazepine: correlation with adverse effects.

Authors:  S R Bareggi; M R Tata; A Guizzaro; R Pirola; A Parisi; C G Monza
Journal:  Int Clin Psychopharmacol       Date:  1994       Impact factor: 1.659

9.  A strategy to reduce cardiovascular disease by more than 80%.

Authors:  N J Wald; M R Law
Journal:  BMJ       Date:  2003-06-28

Review 10.  The increasing complexity of mercaptopurine pharmacogenomics.

Authors:  S Marsh; D J Van Booven
Journal:  Clin Pharmacol Ther       Date:  2009-02       Impact factor: 6.875

View more
  12 in total

1.  Prevention and pharmacovigilance: what should we do, what can we do?

Authors:  I Ralph Edwards
Journal:  Drug Saf       Date:  2012-02-01       Impact factor: 5.606

2.  Preventable and non-preventable adverse drug events in hospitalized patients: a prospective chart review in the Netherlands.

Authors:  Aileen B Dequito; Peter G M Mol; Jasperien E van Doormaal; Rianne J Zaal; Patricia M L A van den Bemt; Flora M Haaijer-Ruskamp; Jos G W Kosterink
Journal:  Drug Saf       Date:  2011-11-01       Impact factor: 5.606

3.  Detecting medication errors in the New Zealand pharmacovigilance database: a retrospective analysis.

Authors:  Desireé L Kunac; Michael V Tatley
Journal:  Drug Saf       Date:  2011-01-01       Impact factor: 5.606

Review 4.  Preventability of drug-related harms - part I: a systematic review.

Authors:  Robin E Ferner; Jeffrey K Aronson
Journal:  Drug Saf       Date:  2010-11-01       Impact factor: 5.606

5.  Assessment of a new instrument for detecting preventable adverse drug reactions.

Authors:  Raja Benkirane; Rachida Soulaymani-Bencheikh; Asmae Khattabi; Ghita Benabdallah; Loubna Alj; Houda Sefiani; Khedidja Hedna; Lahcen Ouammi; Sten Olsson; Shanti N Pal
Journal:  Drug Saf       Date:  2015-04       Impact factor: 5.606

Review 6.  The law of mass action and the pharmacological concentration-effect curve: resolving the paradox of apparently non-dose-related adverse drug reactions.

Authors:  Jeffrey K Aronson; Robin E Ferner
Journal:  Br J Clin Pharmacol       Date:  2015-10-26       Impact factor: 4.335

7.  Characterization of adverse drug reactions causing admission to an intensive care unit.

Authors:  Camilo Rojas-Velandia; Jair Ruiz-Garzón; Juan-Carlos Moscoso-Alcina; Álvaro Vallejos-Narvaéz; Jenny Castro-Canoa; Yuri Bustos-Martínez; Max Flórez-Cutiva; Mabel Contreras-Muñoz; Jully-Carolina Gómez-Gil; Carlos-Alberto Calderón-Ospina
Journal:  Br J Clin Pharmacol       Date:  2017-01-10       Impact factor: 4.335

8.  Adverse drug reactions.

Authors:  Yoon K Loke
Journal:  Br J Clin Pharmacol       Date:  2012-06       Impact factor: 4.335

Review 9.  Comprehensive evaluations of the adverse effects of drugs: importance of appropriate study selection and data sources.

Authors:  Yoon K Loke; Su P Golder; Jan P Vandenbroucke
Journal:  Ther Adv Drug Saf       Date:  2011-04

10.  Quality of pharmacotherapy in old age: focus on lists of Potentially Inappropriate Medications (PIMs) : Consensus statements from the European Science Foundation exploratory workshop.

Authors:  Majda Azermai; Robert R Vander Stichele; Monique M Elseviers
Journal:  Eur J Clin Pharmacol       Date:  2016-04-11       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.